Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.46 CAD | -0.68% | -2.01% | -18.44% |
Sales 2024 * | 1M 733K | Sales 2025 * | 8.12M 5.96M | Capitalization | 111M 81.19M |
---|---|---|---|---|---|
Net income 2024 * | -34M -24.93M | Net income 2025 * | -39M -28.59M | EV / Sales 2024 * | 111 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 13.6 x |
P/E ratio 2024 * |
-3.67
x | P/E ratio 2025 * |
-3.97
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.1% |
Latest transcript on Oncolytics Biotech Inc.
1 day | -0.68% | ||
1 week | -2.01% | ||
1 month | -5.19% | ||
3 months | -3.31% | ||
6 months | -23.16% | ||
Current year | -18.44% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | 01-08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.46 | -0.68% | 5,355 |
24-05-30 | 1.47 | -1.34% | 19,468 |
24-05-29 | 1.49 | -.--% | 69,915 |
24-05-28 | 1.49 | -2.61% | 27,102 |
24-05-27 | 1.53 | +2.68% | 10,099 |
Delayed Quote Toronto S.E., May 31, 2024 at 03:59 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.44% | 81.17M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- ONC Stock